HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Henrickson Laboratory
The Henrickson Lab is focused on understanding the role of T cell dysfunction in chronic allergic and inflammatory disease, including asthma and obesity, as well as rare, monogenic primary immunodeficiency. The team uses complementary approaches in humans and animal models, leveraging detailed immunophenotyping and metabolic characterization of immune dysfunction in patients to identify mechanistic hypotheses to work with animal models and human cells in vitro.
Lab Life Video Series: Henrickson Lab
Researchers in the lab of Sarah Henrickson, MD, PhD, investigate the role of T cell dysfunction in chronic allergic and inflammatory diseases, from asthma and obesity to rare, monogenic primary immunodeficiency. In this installment of our Lab Life video series, meet Dr. Henrickson and her lab members as they describe what makes the Henrickson Lab a unique and impactful place to work.
Leader
Sarah E. Henrickson, MD, PhD
Assistant Professor
Dr. Henrickson investigates the mechanisms of T cell dysfunction in monogenic primary immunodeficiency and chronic inflammatory disease, including asthma and obesity, and primary immunodeficiency.
Dr. Sarah Henrickson identified a newborn’s immunodeficiency in 2015, and an international team characterized the rare disease this year.
Cornerstone Blog
Scientists suggest IgA “tunes” which microbes can cross mucosal barriers. Their findings may inform better treatments for IgA deficiency.
Cornerstone Blog
Two CHOP researchers receive the Individual Biomedical Research Award from the Hartwell Foundation, which will fund early-stage, innovative projects.
Cornerstone Blog
Our October Faculty Spotlight, Dr. Sarah Henrickson, is fascinated by the common threads between common inflammatory diseases.